{
    "xml": "<topic id=\"PHP1607\" outputclass=\"drug\" rev=\"1.18\" type=\"drug\" namespace=\"/drugs/dried-prothrombin-complex\" basename=\"dried-prothrombin-complex\" title=\"DRIED PROTHROMBIN COMPLEX\">\n<title>DRIED PROTHROMBIN COMPLEX</title>\n<body>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_135079060\" title=\"Blood coagulation factors\">Blood coagulation factors</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<p outputclass=\"synonyms\">Human Prothrombin Complex</p>\n</body>\n<topic id=\"PHP69621\" outputclass=\"indicationsAndDose\" rev=\"1.26\" parent=\"/drugs/dried-prothrombin-complex\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment and peri-operative prophylaxis of haemorrhage in patients with congenital deficiency of factors II, VII, IX, or X if purified specific coagulation factors not available</p>\n<p outputclass=\"therapeuticIndication\">Treatment and peri-operative prophylaxis of haemorrhage in patients with acquired deficiency of factors II, VII, IX, or X (e.g. during warfarin treatment)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>(consult haematologist).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Major bleeding in patients on warfarin following phytomenadione</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>25&#8211;50&#8239;units/kg.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69678\" outputclass=\"contraindications\" rev=\"1.7\" parent=\"/drugs/dried-prothrombin-complex\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Angina</ph>; <ph outputclass=\"contraindication\">history of heparin induced thrombocytopenia</ph>; <ph outputclass=\"contraindication\">recent myocardial infarction (except in life-threatening haemorrhage following overdosage of oral anticoagulants, and before induction of fibrinolytic therapy)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69698\" outputclass=\"cautions\" rev=\"1.7\" parent=\"/drugs/dried-prothrombin-complex\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Disseminated intravascular coagulation</ph>; <ph outputclass=\"caution\">history of myocardial infarction or coronary heart disease</ph>; <ph outputclass=\"caution\">postoperative use</ph>; <ph outputclass=\"caution\">risk of thrombosis</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69529\" outputclass=\"sideEffects\" rev=\"1.18\" parent=\"/drugs/dried-prothrombin-complex\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Headache</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"veryRare\">\n<p outputclass=\"title\">Very rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Anaphylaxis</ph>; <ph outputclass=\"sideEffect\">antibody formation</ph>; <ph outputclass=\"sideEffect\">hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">pyrexia</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Disseminated intravascular coagulation</ph>; <ph outputclass=\"sideEffect\">nephrotic syndrome</ph>; <ph outputclass=\"sideEffect\">thrombotic events</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP69636\" outputclass=\"hepaticImpairment\" parent=\"/drugs/dried-prothrombin-complex\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"additionalMonitoringInHepaticImpairment\">\n<sectiondiv>\n<p>Monitor closely in hepatic impairment (risk of thromboembolic complications).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP57265\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/dried-prothrombin-complex\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Dried prothrombin complex is prepared from human plasma by a suitable fractionation technique, and contains factor IX, together with variable amounts of factors II, VII, and X.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78213\" namespace=\"/treatment-summaries/oral-anticoagulants\" title=\"Oral anticoagulants\" count=\"2\" rel=\"backlink\">Oral anticoagulants</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n</links>\n</topic>",
    "id": "PHP1607",
    "outputclass": "drug",
    "rev": "1.18",
    "type": "drug",
    "namespace": "/drugs/dried-prothrombin-complex",
    "basename": "dried-prothrombin-complex",
    "title": "DRIED PROTHROMBIN COMPLEX",
    "drugClassification": [
        "Blood coagulation factors"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "synonyms": [
        "Human Prothrombin Complex"
    ],
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment and peri-operative prophylaxis of haemorrhage in patients with congenital deficiency of factors II, VII, IX, or X if purified specific coagulation factors not available",
                        "html": "Treatment and peri-operative prophylaxis of haemorrhage in patients with congenital deficiency of factors II, VII, IX, or X if purified specific coagulation factors not available"
                    },
                    {
                        "textContent": "Treatment and peri-operative prophylaxis of haemorrhage in patients with acquired deficiency of factors II, VII, IX, or X (e.g. during warfarin treatment)",
                        "html": "Treatment and peri-operative prophylaxis of haemorrhage in patients with acquired deficiency of factors II, VII, IX, or X (e.g. during warfarin treatment)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "(consult haematologist).",
                        "html": "<p>(consult haematologist).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Major bleeding in patients on warfarin following phytomenadione",
                        "html": "Major bleeding in patients on warfarin following phytomenadione"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "25&#8211;50 units/kg.",
                        "html": "<p>25&#8211;50&#8239;units/kg.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Angina",
                "html": "Angina"
            },
            {
                "type": "contraindications",
                "textContent": "history of heparin induced thrombocytopenia",
                "html": "history of heparin induced thrombocytopenia"
            },
            {
                "type": "contraindications",
                "textContent": "recent myocardial infarction (except in life-threatening haemorrhage following overdosage of oral anticoagulants, and before induction of fibrinolytic therapy)",
                "html": "recent myocardial infarction (except in life-threatening haemorrhage following overdosage of oral anticoagulants, and before induction of fibrinolytic therapy)"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Disseminated intravascular coagulation",
                "html": "Disseminated intravascular coagulation"
            },
            {
                "type": "cautions",
                "textContent": "history of myocardial infarction or coronary heart disease",
                "html": "history of myocardial infarction or coronary heart disease"
            },
            {
                "type": "cautions",
                "textContent": "postoperative use",
                "html": "postoperative use"
            },
            {
                "type": "cautions",
                "textContent": "risk of thrombosis",
                "html": "risk of thrombosis"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Headache",
                        "html": "Headache",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ],
                "veryRare": [
                    {
                        "type": "veryRare",
                        "textContent": "Anaphylaxis",
                        "html": "Anaphylaxis",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "antibody formation",
                        "html": "antibody formation",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "hypersensitivity reactions",
                        "html": "hypersensitivity reactions",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    },
                    {
                        "type": "veryRare",
                        "textContent": "pyrexia",
                        "html": "pyrexia",
                        "frequency": "veryRare",
                        "specificity": {
                            "textContent": "Very rare",
                            "html": "Very rare"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Disseminated intravascular coagulation",
                        "html": "Disseminated intravascular coagulation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nephrotic syndrome",
                        "html": "nephrotic syndrome",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thrombotic events",
                        "html": "thrombotic events",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        }
    },
    "hepaticImpairment": {
        "additionalMonitoring": [
            {
                "type": "additionalMonitoring",
                "textContent": "Monitor closely in hepatic impairment (risk of thromboembolic complications).",
                "html": "<p>Monitor closely in hepatic impairment (risk of thromboembolic complications).</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Dried prothrombin complex is prepared from human plasma by a suitable fractionation technique, and contains factor IX, together with variable amounts of factors II, VII, and X.",
                "html": "<p>Dried prothrombin complex is prepared from human plasma by a suitable fractionation technique, and contains factor IX, together with variable amounts of factors II, VII, and X.</p>"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78213",
                "label": "Oral anticoagulants",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ]
    }
}